Hospira HSP (news,
chart,
quote) - HSP option implied volatility Collapses as HSP rallies on 4Q performance
HSP, a specialty pharmaceutical and medication delivery company, is recently up $2.94 to $38.84. BAMO say's "4Q EPS beat on strong topline performance." BAMO has a 12-month price target of $42 on HSP and say's "company provides 2007 guidance range above consensus." HSP March option implied volatility of 22 is below its 26-week average of 32 and a over all level of 40 from yesterday according to Track Data suggesting decreasing price fluctuations.
DISCLAIMER: RED Option, in an attempt to provide the best resources from some of the industry's most capable people, has introduced our Market Minute commentary. RED Option does not endorse this commentary or information as trade recommendations nor does it have any input whatsoever into the decision making. Any content for the Market Minute is the sole opinion of the author.
